• Users Online: 522
  • Print this page
  • Email this page

    Article Cited by others

ORIGINAL ARTICLE

Acyclovir in pityriasis rosea: An observer-blind, randomized controlled trial of effectiveness, safety and tolerability

Das Anupam, Sil Amrita, Das Nilay Kanti, Roy Kunal, Das Amal Kanti, Bandyopadhyay Debabrata

Year : 2015| Volume: 6| Issue : 3 | Page no: 181-184

   This article has been cited by
 
1 L-lysine therapy to control the clinical evolution of pityriasis rosea: Clinical case report and literature review
Maria Cristina Pedrazini, Francisco Carlos Groppo
Dermatologic Therapy. 2021; 34(1)
[Pubmed]  [Google Scholar] [DOI]
2 Atypical pityriasis rosea in a young Colombian woman. Case report
Julián Felipe Porras-Villamil, Angela Catalina Hinestroza, Gabriela Andrea López-Moreno, Doris Juliana Parra-Sepúlveda
Case reports. 2021; 7(2): 8
[Pubmed]  [Google Scholar] [DOI]
3 Is acyclovir effective in the treatment of pityriasis rosea?
Tuananh Pham, Ryan Edwards, Rhys Crasto
Evidence-Based Practice. 2020; 23(11): 47
[Pubmed]  [Google Scholar] [DOI]
4 The efficacy of oral acyclovir during early course of pityriasis rosea: a systematic review and meta-analysis
Hua-Ching Chang,Chih-Wei Sung,Ming-Hsiu Lin
Journal of Dermatological Treatment. 2018; : 1
[Pubmed]  [Google Scholar] [DOI]
5 Effectiveness of acyclovir in the treatment of pityriasis rosea. A systematic review and meta-analysis
Milton Rodriguez-Zuniga,Natalie Torres,Herney Garcia-Perdomo
Anais Brasileiros de Dermatologia. 2018; 93(5): 686
[Pubmed]  [Google Scholar] [DOI]
6 Clinical variants of pityriasis rosea
Francisco Urbina,Anupam Das,Emilio Sudy
World Journal of Clinical Cases. 2017; 5(6): 203
[Pubmed]  [Google Scholar] [DOI]
7 A position statement on the management of patients with pityriasis rosea
A. Chuh,V. Zawar,G. Sciallis,W. Kempf
Journal of the European Academy of Dermatology and Venereology. 2016;
[Pubmed]  [Google Scholar] [DOI]

 

Read this article